Literature DB >> 11268114

Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis.

K Y Ho1, C C Tsai, C P Chen, J S Huang, C C Lin.   

Abstract

The antimicrobial activity of honokiol and magnolol, the main constituents of Magnolia officinalis was investigated. The antimicrobial activity was assayed by the agar dilution method using brain heart infusion medium and the minimum inhibitory concentration (MIC) were determined for each compound using a twofold serial dilution assay. The results showed that honokiol and magnolol have a marked antimicrobial effect (MIC = 25 microg/mL) against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Micrococcus luteus and Bacillus subtilis, but did not show antimicrobial activity (MIC > or = 100 microg/mL) for Shigella flexneii, Staphylococcus epidermidis, Enterobacter aerogenes, Proteus vulgaris, Escherichia coli and Pseudomonas aeruginosa. Our results indicate that honokiol and magnolol, although less potent than tetracycline, show a significant antimicrobial activity for periodontal pathogens. Hence we suggest that honokiol and magnolol might have the potential to be an adjunct in the treatment of periodontitis. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268114     DOI: 10.1002/ptr.736

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  42 in total

1.  Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.

Authors:  Te I Weng; Hsiao Yi Wu; Chia Wei Kuo; Shing Hwa Liu
Journal:  Intensive Care Med       Date:  2011-01-29       Impact factor: 17.440

2.  Inhibitory Effects of Honokiol on the Voltage-Gated Potassium Channels in Freshly Isolated Mouse Dorsal Root Ganglion Neurons.

Authors:  Anqi Sheng; Yan Zhang; Guang Li; Guangqin Zhang
Journal:  Neurochem Res       Date:  2017-11-24       Impact factor: 3.996

3.  Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway.

Authors:  Ju-Hee Lee; Ji Yun Jung; Eun Jeong Jang; Kyung Hwan Jegal; Soo Young Moon; Sae Kwang Ku; Seung Ho Kang; Il Je Cho; Sook Jahr Park; Jong Rok Lee; Rong Jie Zhao; Sang Chan Kim; Young Woo Kim
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

Review 4.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

5.  Magnolol reduces bleomycin-induced rodent lung fibrosis.

Authors:  Xiangfeng Zhang; Han Huang; Huijuan Chang; Xiuhong Jin
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells.

Authors:  Yoshitaka Hosokawa; Ikuko Hosokawa; Kazumi Ozaki; Takashi Matsuo
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

Review 7.  Honokiol: a novel natural agent for cancer prevention and therapy.

Authors:  S Arora; S Singh; G A Piazza; C M Contreras; J Panyam; A P Singh
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

Review 8.  Honokiol, a multifunctional antiangiogenic and antitumor agent.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

9.  Antiprotozoal activity of medicinal plants against Ichthyophthirius multifiliis in goldfish (Carassius auratus).

Authors:  Yang-Lei Yi; Cheng Lu; Xue-Gang Hu; Fei Ling; Gao-Xue Wang
Journal:  Parasitol Res       Date:  2012-08-05       Impact factor: 2.289

10.  Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.

Authors:  Shu-Er Yang; Ming-Tsuen Hsieh; Tung-Hu Tsai; Shih-Lan Hsu
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.